The BC Centre for Excellence in HIV/AIDS (BC-CfE) hosted a national summit in early June to address a troubling reality: The latest available government statistics for 2023 show a 35% uptick in HIV cases in Canada compared to 2022. Key […]
Rising HIV Cases Signal Crisis in Canadian Prevention Efforts Read More »
Life sciences venture capital firms continue to evolve their approaches to translating academic research into commercial therapies. Boston-based 28 Capital, co-founded by biotech entrepreneur John Boyce and venture capitalist Audrey Warner, announced the launch of a new platform focused on
Biotech VC Firm 28 Capital Emerges from Tiger Gene with New Platform Read More »
Brii Biosciences has secured complete ownership of BRII-179, a hepatitis B immunotherapy candidate, through an $18 million acquisition from VBI Vaccines and its creditors. The acquisition gives Brii full control over intellectual property, manufacturing, and supply while eliminating future milestone
Brii Biosciences BRII-179 Acquisition Read More »
Male fertility is an increasing concern, and in response, a startup, Legacy, has raised an additional $7.5M to scale sperm testing and storage. At-home kits are shipped directly to clients and then back to Legacy’s state-of-the-art andrology labs and cryo-storage
Legacy Raises $7.5M Investment to Scale Sperm Testing and Storage Read More »
Research at Penn Dental Medicine is uncovering unique properties of jaw stem cells. Unlike stem cells from other bones like hips, those from the maxilla and mandible have shown superior regenerative abilities. A deeper understanding could lead to potential advancements
Unlocking Jaw Stem Cells: Pioneering Repair and Regeneration Read More »
